Company / FCF Margin
ARDELYX, INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-10.8%
FY2025
5-year range
-1529.3% / -10.8%
FY2021-FY2025
Trend
+21.3%
vs FY2024
Sector context
#69 of 134
Health Care
What the data says
At -10.8%, ARDELYX, INC.'s fcf margin ranks #69 of 134 in the Health Care sector. FCF Margin has increased for 4 consecutive years, from -1529.3% in FY2021 to -10.8% in FY2025.
Based on SEC 10-K filings.
-10.8% in FY2025 with a 5-year CAGR of +1069.1%.
Improved from -72.4% to -10.8% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +123.6pp
- 5-Year Change
- +1069.1pp
- 10-Year Change
- -
Sector benchmark
#69 of 134 in Health CareTop 51% of 134This company -10.8% Sector average -637.8%
▼
+98.3% above sector average
Key checks
Key Insights
- ARDELYX, INC.'s fcf margin has grown for 4 consecutive years.
- In FY2025, fcf margin increased 21.3% year-over-year.
- Currently 627.0pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.41 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -10.8% | +21.3% |
| FY2024 | -13.7% | +81.0% |
| FY2023 | -72.4% | +46.2% |
| FY2022 | -134.4% | +91.2% |
| FY2021 | -1529.3% | -41.6% |
| FY2020 | -1079.9% | +25.8% |
| FY2019 | -1454.4% | +99.4% |
| FY2018 | -235283.3% | -74976.8% |
| FY2017 | -313.4% | -958.6% |
| FY2016 | 36.5% | +111.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026